Skip to main content
GutCited

Bifidobacterium bifidum 관련 Functional Dyspepsia

C

B. bifidum YIT 10347 showed improvement in acid-related and gas-related dyspepsia symptoms in Japanese studies. Mixed results in Western populations.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dbifidobacterium\u002Dbifidum\u0026condition\u003Dfunctional\u002Ddyspepsia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

결론

B. bifidum YIT 10347 showed improvement in acid-related and gas-related dyspepsia symptoms in Japanese studies. Mixed results in Western populations.

Key Study Findings

Controlled Clinical Trial n=54 3.0 weeks
[Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with …
Dose: 350 mg vs: None Outcome: IBS symptom improvement 효과: None None

대상 집단: Irritable bowel syndrome with diarrhea and antibiotic-associated diarr

Randomized Controlled Trial n=100 4 weeks Double-blind
Bifidobacterium bifidum YIT 10347 fermented milk exerts beneficial effects on gastrointestinal discomfort and symptoms in …
Dose: 100 mL/day fermented milk vs: Placebo fermented milk Outcome: GI symptom scores (m-FSSG, GSRS) 효과: None None

대상 집단: Healthy Japanese adults with GI discomfort

Randomized Controlled Trial Double-blind
Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or …
Dose: None vs: Placebo + eradication regimen Outcome: H. pylori eradication rate and adverse effects 효과: None None

대상 집단: Adults with H. pylori infection

Key Statistics

4

연구

500

참여자

Positive

C

등급

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
1-10 billion CFU/day
dyspepsiasupport:
1 billion CFU/day (YIT 10347 strain)

상한량: Well-tolerated up to 10 billion CFU/day in clinical trials

연구에서 사용된 용량

용량 기간 효과 N
350 mg 3.0 weeks Positive 54
100 mL/day fermented milk 4 weeks Positive 100
100 mL/day 4.0 weeks Positive --
None -- Neutral --

권장 복용 시간: On an empty stomach or before meals

Safety & Side Effects

보고된 부작용

  • Mild gas and bloating during initial use
  • Occasional abdominal discomfort
  • Rare loose stools
  • Very rare: bacteremia in immunocompromised individuals

알려진 상호작용

  • Antibiotics (may reduce probiotic viability; space dosing 2 hours apart)
  • Immunosuppressants (use with caution in immunocompromised patients)

일일 최대 섭취 허용량: Well-tolerated up to 10 billion CFU/day in clinical trials

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Bifidobacterium bifidum help with Functional Dyspepsia?
Based on 4 studies with 500 participants, there is limited but promising evidence that Bifidobacterium bifidum may support Functional Dyspepsia management. Our evidence grade is C (Some Evidence).
How much Bifidobacterium bifidum should I take for Functional Dyspepsia?
Studies have used various dosages. A commonly studied range is 1-10 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Bifidobacterium bifidum?
Reported side effects may include Mild gas and bloating during initial use, Occasional abdominal discomfort, Rare loose stools, Very rare: bacteremia in immunocompromised individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Bifidobacterium bifidum and Functional Dyspepsia?
We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 500 total participants. The overall direction of effect is positive.

Related Evidence

관련 다른 성분: Functional Dyspepsia

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.